Features

Features

Drug delivery innovations push forth women’s health

From nanoparticles to transdermal patches, Pharmaceutical Technology takes a look at the latest in drug delivery technologies for women's health.

Features

Harnessing pharmacovigilance to turn reactive investigation into active discovery

Features

Continuous monitoring expands aseptic knowledge and data in real time

Features

Can pharma overcome generative AI’s bias problem?

Features

Magazine: What’s next for AAV gene therapies in 2024?

Features

The top emerging pharmaceutical companies in the US

Features

Molecular glues are the latest craze in pharma research, but what are they?

Features

Donanemab: FDA AdCom will put spotlight on tau enrolment and ARIA concerns

Features

Magazine: Biotechs surf obesity drug wave to go beyond GLP-1RAs

Features

Is HIV-TB coinfection treatment entering a new frontier?

Natasha Spencer-Jolliffe

Features

Traceability technologies tighten supply chain fakery

Natasha Spencer-Jolliffe

Features

Patient organisations need to tackle transparency

Natasha Spencer-Jolliffe

Features

What’s next for AAV gene therapies in 2024?

Features

Beyond approval: Patients pursue alternate paths to get rare disease treatments

Features

Anticipation rises for RSV rollout as positive data emerges

Features

Psychedelic treatments for mental health: Is there substance behind the hype?

Features

China-US tensions are spilling into the biotech sector

Features

Biotechs ride obesity drug wave with novel approaches that go beyond GLP-1RAs

Features

The opioid crisis: Different delivery systems tackle treatment needs

Features

Another recall: does Philips have a quality control problem?

Features

Out with the old, in with the new: Decoding biosimilar access with VPAG

Features

CAR-T therapies and cancer risk: No easy answers for the FDA

Phalguni Deswal

Features

A ‘sense of urgency’ swirls in the UK pharma regulatory landscape

Natasha Spencer-Jolliffe

Features

How will the US-UK strikes on Houthi rebels in Yemen affect Red Sea trade?

Sorin-Andrei Dojan

Features

Switching sales: Investigating the financial impacts of FDA’s priority vouchers

Features

What the latest FDI deals tell us about India’s growing economy

Sorin-Andrei Dojan

Features

Inside the world of priority review vouchers where ‘time is money’ – Part I

Features

Magazine: Pharma’s path to Net Zero: Targeting Scope 3 emissions

Features

Difficult biotech investment ecosystem forces focus on value

Features

2023 in review: Cancer vaccines dose up on advances with tailored approaches

Features

Magazine: What’s in a name

Features

Pharma breakthroughs: 10 novel drug approvals that made headlines in 2023

Features

Regulatory changes in the US and UK to watch in 2024

Joshua Silverwood

Features

How COP28 raised the profile of ‘super pollutants’ like black carbon

Features

Pharmaceutical Technology’s most-read stories of 2023

Features

Magazine: Advancing islet transplantation for type 1 diabetes

Features

FDI forecasts and trends to watch in 2024

Features

Pharma readies for climate disasters amidst supply chain concerns

Sign up to the newsletter: In Brief

Your corporate email address *

First name *

Last name *

Company name *

Job title *

I would also like to subscribe to:

Pharma Technology Focus : Pharmaceutical Technology Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close